Cargando…
MON-225 A Randomized Placebo-Controlled Trial of Low-Dose Testosterone Therapy in Women with Anorexia Nervosa
Background: Anorexia nervosa is a serious psychiatric illness with significant mortality and no approved medical therapies. Comorbid affective disorders are highly prevalent, and we have shown that relative androgen deficiency in anorexia nervosa is associated with depression and anxiety symptom sev...
Autores principales: | Kimball, Allison, Schorr, Melanie, Meenaghan, Erinne, Bachmann, Katherine, Eddy, Kamryn, Misra, Madhusmita, Schoenfeld, David, Klibanski, Anne, Miller, Karen |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Endocrine Society
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6550920/ http://dx.doi.org/10.1210/js.2019-MON-225 |
Ejemplares similares
-
SAT-167 Dehydroepiandrosterone Sulfate (DHEAS) Levels Predict Weight Gain in Women with Anorexia Nervosa
por: Kimball, Allison, et al.
Publicado: (2020) -
RF06 | PSAT147 Impairments in volumetric bone mineral density, bone microarchitecture, and estimated strength in women with atypical anorexia nervosa
por: Eddy, Kamryn, et al.
Publicado: (2022) -
RF30 | PSAT172 Effects of 12 Months of Alendronate Therapy Subsequent to 12 Months of Denosumab Administration in Women With Anorexia Nervosa
por: Haines, Melanie, et al.
Publicado: (2022) -
Sequential Therapy With Recombinant Human IGF-1 Followed by Risedronate Increases Spine Bone Mineral Density in Women With Anorexia Nervosa
por: Haines, Melanie S, et al.
Publicado: (2021) -
Transdermal Estrogen in Women With Anorexia Nervosa: An Exploratory Pilot Study
por: Resulaj, Megi, et al.
Publicado: (2019)